(Q74117541)
Statements
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy (English)
Clemens A Schmitt
Jordan S Fridman
Meng Yang
Eugene Baranov
Robert M Hoffman
scientific article published on 01 May 2002
No description defined